Concepedia

Fook-Thean Lee

FL

Statistics

Publications

5

Citations

236

H-Index

5

Active since

1986

Affiliations

Ludwig Cancer Research(Current)

Fook-Thean Lee is an author at Ludwig Cancer Research specializing in cancer therapeutics, immunology, and immunotherapy.

Top concepts

Publications per year

1986–2020

5

Publications

5

Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.

Fook-Thean Lee, Christopher L. Hall, Angela Rigopoulos et al. · PubMed · 2001 · 78 citations

A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.

Ian D. Davis, Gregory A. Wiseman, Fook-Thean Lee et al. · PubMed · 2007 · 59 citations · Full text

, , +13

Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.

Kate Clarke, Fook-Thean Lee, Martin W. Brechbiel et al. · PubMed · 2000 · 57 citations

, , +14

First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers

Andrew M. Scott, Timothy Akhurst, Fook-Thean Lee et al. · Theranostics · 2020 · 23 citations · Full text

Multiple phosphorylation sites of rat liver glycogen synthase

Yuhuan Wang, Marcella Camici, Fook-Thean Lee et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1986 · 19 citations

, , +4

1–5 of 5